Literature DB >> 10508259

Ligand binding specificities and signal transduction pathways of Fc gamma receptor IIc isoforms: the CD32 isoforms expressed by human NK cells.

D Metes1, M Manciulea, D Pretrusca, H Rabinowich, L K Ernst, I Popescu, A Calugaru, A Sulica, W H Chambers, R B Herberman, P A Morel.   

Abstract

We recently reported that human NK cells express, in addition to CD16 [Fcgamma receptor (FcgammaR) IIIA], a second type of FcgammaR, namely CD32 (FcgammaRII). Molecular characterization of CD32 transcripts expressed by highly purified NK cells revealed that they predominantly express products of the FcgammaRIIC gene. Using stable Jurkat transfectants we have analyzed the functional properties of two FcgammaRIIc-specific isoforms isolated from NK cells, namely FcgammaRIIc1 and FcgammaRIIc3, which differ in their cytoplasmic tails. The ligand binding specificity for both murine and human IgG isotypes was found to be similar to that observed for FcgammaRIIb isoforms. Immunoprecipitation studies of FcgammaRIIc isoforms expressed in Jurkat cells revealed a protein of around 40 kDa for FcgammaRIIc1, and a protein of around 32 kDa for FcgammaRIIc3. Signal transduction studies performed on FcgammaRIIc1-expressing Jurkat cells indicated that this molecule is functional, i. e. capable of Ca2+ mobilization and activation of Lck, Zap-70 and Syk protein tyrosine kinases, although the CD3 zeta chain was not found to functionally associate with FcgammaRIIc1. In contrast, FcgammaRIIc3 transfectants showed an impaired ability of this molecule to mobilize Ca2+, but activation of Lck was detected following activation via FcgammaRIIc3. These studies demonstrate the functional activity of FcgammaRIIc isoforms and suggest that the presence of CD32, in addition to CD16, on NK cells may have functional relevance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508259     DOI: 10.1002/(SICI)1521-4141(199909)29:09<2842::AID-IMMU2842>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.

Authors:  Shivani Srivastava; David Pelloso; Hailin Feng; Larry Voiles; David Lewis; Zdenka Haskova; Margaret Whitacre; Stephen Trulli; Yi-Jiun Chen; John Toso; Zdenka L Jonak; Hua-Chen Chang; Michael J Robertson
Journal:  Cancer Immunol Immunother       Date:  2013-04-19       Impact factor: 6.968

3.  Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.

Authors:  Xinrui Li; Jianming Wu; Travis Ptacek; David T Redden; Elizabeth E Brown; Graciela S Alarcón; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Richard A Kaslow; Robert P Kimberly; Jeffrey C Edberg
Journal:  Sci Transl Med       Date:  2013-12-18       Impact factor: 17.956

4.  Genotyping Single Nucleotide Polymorphisms and Copy Number Variability of the FCGRs Expressed on NK Cells.

Authors:  Amy K Erbe; Wei Wang; Mikayla Gallenberger; Jacquelyn A Hank; Paul M Sondel
Journal:  Methods Mol Biol       Date:  2016

5.  Expression of Fc Fragment Receptors of Immunoglobulin G (FcγRs) in Rat Hepatic Stellate Cells.

Authors:  Hong Shen; Manna Zhang; Kelly Kaita; Gerald Y Minuk; Julia Rempel; Yuewen Gong
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 6.  CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity.

Authors:  Eugenia Corrales-Aguilar; Katja Hoffmann; Hartmut Hengel
Journal:  Semin Immunopathol       Date:  2014-10-07       Impact factor: 9.623

Review 7.  Human FcR polymorphism and disease.

Authors:  Xinrui Li; Andrew W Gibson; Robert P Kimberly
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 8.  Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine.

Authors:  Sietse Q Nagelkerke; David E Schmidt; Masja de Haas; Taco W Kuijpers
Journal:  Front Immunol       Date:  2019-10-03       Impact factor: 7.561

Review 9.  Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms.

Authors:  Emilie Lebraud; Maëva Eloudzeri; Marion Rabant; Baptiste Lamarthée; Dany Anglicheau
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

10.  Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III.

Authors:  Eugenia Corrales-Aguilar; Mirko Trilling; Katja Hunold; Manuela Fiedler; Vu Thuy Khanh Le; Henrike Reinhard; Katrin Ehrhardt; Eva Mercé-Maldonado; Enver Aliyev; Albert Zimmermann; David C Johnson; Hartmut Hengel
Journal:  PLoS Pathog       Date:  2014-05-15       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.